Stock Events
Stock Events
Search...
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Ligand Pharmaceuticals (LGND) Q3 2018 Earnings
LGND
6
Aug
Confirmed
Q4 2017
Q1 2018
Q2 2018
Q3 2018
0.6
1.26
1.93
2.59
Details
Expected EPS
2.34
Actual EPS
2.59
Surprise EPS
0.25
Surprise Percent
+10.68%
Description
Ligand Pharmaceuticals (LGND) has reported earnings of 2.59 per share for Q3 2018.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist